Table 3 10-year cardiovascular cumulative risk of 210 left-sided breast cancer patients following radiotherapy after taking into account an increase of 7.4% per Gy in mean heart dose of the individual treatment plans. FB: free-breathing, DIBH: deep inspiration breath-hold, EAR: excess absolute risk
From: Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks
Non-Diabetic patients (n = 200) | Diabetic patients (n = 10) | Entire cohort (n = 210) | ||||
|---|---|---|---|---|---|---|
Following FB-RT | Following DIBH-RT | Following FB-RT | Following DIBH-RT | Following FB-RT | Following DIBH-RT | |
Procam Score | ||||||
Baseline risk | 3.11% | 11.76% | 3.52% | |||
Mean EAR | + 0.50% | + 0.30% | + 1.92% | + 1.52% | + 0.57% | + 0.36% |
Mean cumulative risk | 3.61% | 3.41% | 13.68% | 13.28% | 4.09% | 3.88% |
Framingham Score | ||||||
Baseline risk | 3.39% | 24.23% | 4.38% | |||
Mean EAR | + 0.55% | + 0.34% | + 4.64% | + 3.37% | + 0.75% | + 0.49% |
Mean cumulative risk | 3.94% | 3.73% | 28.87% | 27.60% | 5.13% | 4.87% |
Reynolds Score | ||||||
Baseline risk | 3.58% | 10.66% | 3.91% | |||
Mean EAR | + 0.60% | + 0.37% | + 1.88% | + 1.47% | + 0.67% | + 0.42% |
Mean cumulative risk | 4.18% | 3.95% | 12.54% | 12.13% | 4.58% | 4.33% |